Metabolic syndrome and coronary artery disease in ossabaw compared with yucatan swine

Comparative Medicine

Volumn 60, Issue 4, 2010, Pages 300-315

  Neeb, Zachary P ^a   Edwards, Jason M ^a   Alloosh, Mouhamad ^a   Long, Xin ^a   Mokelke, Eric A ^a   Sturek, Michael ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BARE METAL STENT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; EXPERIMENTAL MODEL; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OSSABAW SWINE; SMOOTH MUSCLE FIBER; STENOSIS; SWINE; YUCATAN SWINE;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CALCIUM; CHOLESTEROL, DIETARY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; METABOLIC SYNDROME X; SPECIES SPECIFICITY; STENTS; SWINE;

EID: 77958025772     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. Alloosh M, Pratt JH, Sturek M, Basile DP. 2008. Elevated renin and enhanced adrenal steroidogenesis in the Ossabaw miniature swine model of the metabolic syndrome. FASEB J 22:736.7.
2. AVMA Panel on Euthanasia. American Veterinary Medical Association. 2001. 2000 Report of the AVMA panel on euthanasia. J Am Vet Med Assoc 218:669-696.
3. Bellinger DA, Merricks EP, Nichols TC. 2006. Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J 47:243-258.
4. Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH. 2009. Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234:683-692.
5. Ca channels in metabolic syndrome. Am J Physiol Heart Circ Physiol 297:H1629-H1637.
6. + channels to ischemic coronary vasodilation. Am J Physiol Heart Circ Physiol 298:H1182-H1189.
7. Ca channels to local metabolic coronary vasodilation: effects of metabolic syndrome. Am J Physiol Heart Circ Physiol 298:H966-H973.
8. Boullion RD, Mokelke EA, Wamhoff BR, Otis CR, Wenzel J, Dixon JL, Sturek M. 2003. Porcine model of diabetic dyslipidemia: insulin and feed algorithms for mimicking diabetes in humans. Comp Med 53:42-52.
9. Bratz IN, Dick GM, Tune JD, Edwards JM, Neeb ZP, Dincer UD, Sturek M. 2008. Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol 294:H2489-H2496.
10. Camici PG, Crea F. 2007. Coronary microvascular dysfunction. N Engl J Med 356:830-840.
11. Carroll JA, Daniel JA, Keisler DH, Matteri RL. 1999. Nonsurgical catheterization of the jugular vein in young pigs. Lab Anim 33:129-134.
12. Christoffersen BO, Grand N, Golozoubova V, Svendsen O, Raun K. 2007. Gender-associated differences in metabolic syndrome-related parameters in Gottingen minipigs. Comp Med 57:493-504.
13. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Merger C, Kukreja N, Juni P, Sianos G, Hellige G, Van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. 2007. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large 2-institutional cohort study. Lancet 369:667-678.
14. 2+ store in porcine coronary artery smooth muscle. Diabetes 45:876-880.
15. Dixon JL, Shen S, Vuchetich JP, Wysocka E, Sun G, Sturek M. 2002. Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. J Lipid Res 43:1618-1629.
16. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. 2006. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56:35-45.
17. Eckel RH, Kahn R, Robertson RM, Rizza RA. 2006. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113:2943-2946. (Pubitemid 44297236)
18. 1 receptors in neointimal hyperplasia and in-stent stenosis in Ossabaw miniature swine. Coron Artery Dis 19:27-31.
19. 2+ entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc Res 85:631-640.
20. Flum DR, Devlin A, Wright AS, Figueredo E, Alyea E, Hanley PW, Lucas MK, Cummings DE. 2007. Development of a porcine Rouxen-Y gastric bypass survival model for the study of postsurgical physiology. Obes Surg 17:1332-1339.
21. Friedman JM. 2002. The function of leptin in nutrition, weight, and physiology. Nutr Rev 60:S1-S14.
22. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
23. Gal D, Isner JM. 1992. Atherosclerotic Yucatan microswine as a model for novel cardiovascular interventions and imaging, p 118-140. In: Swindle MM, Moody DC, Phillips LD, editors. Swine as models in biomedical research. Ames (IA): Iowa State University Press.
24. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. 2001. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 50:1654-1665.
25. 2+ entry in human and bovine endothelial cells. J Physiol 482:259-274.
26. Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC, Tittus J, Parhofer K, Becker C, Reiser M, Knez A, Leber AW. 2009. Pericardial adipose tissue determined by dual-source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol 29:781-786.
27. Grundy SM. 2007. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92:399-404.
28. Grundy SM, Brewer HB, Cleeman JI, Smith SC Jr, Lenfant C. 2004. Definition of the metabolic syndrome. Circulation 109:433-438.
29. Hainsworth DP, Katz ML, Sanders DA, Sanders DN, Wright EJ, Sturek M. 2002. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus. Comp Med 52:523-529.
30. Hall JE. 2003. The kidney, hypertension, and obesity. Hypertension 41:625-633.
31. 2+-ATPase uptake is impaired in coronary smooth muscle distal to chronic occlusion. Am J Physiol Heart Circ Physiol 281:H223-H231.
32. Hill BJF, Dixon JL, Sturek M. 2001. Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. Atherosclerosis 159:117-124.
33. A receptor-mediated calcium mobilization and contraction in organ cultured porcine coronary arteries. J Pharmacol Exp Ther 295:484-491.
34. Hill BJF, Price EM, Dixon JL, Sturek M. 2003. Increased calcium buffering in coronary smooth muscle cells from diabetic dyslipidemic pigs. Atherosclerosis 167:15-23.
35. Hill BJF, Wamhoff BR, Sturek M. 2001. Functional nucleotide receptor expression and sarcoplasmic reticulum morphology in dedifferentiated porcine coronary smooth muscle cells. J Vasc Res 38:432-443.
36. Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H, McClain DA, McIndoe R, Wassef MK, Rabadan-Diehl C, Goldberg IJ. 2007. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res 100:1415-1427.
37. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
38. Johnson GJ, Griggs TR, Badimon L. 1999. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. Thromb Haemost 81:835-843.
39. Korte FS, Mokelke EA, Sturek M, McDonald KS. 2005. Exercise improves impaired ventricular function and alterations of cardiac myofibrillar proteins in diabetic dyslipidemic pigs. J Appl Physiol 98:461-467.
40. Kreutz RP, Alloosh M, Neeb ZP, Kreutz Y, Flockhart DA, Sturek M. 2009. Metabolic syndrome in Ossabaw miniature swine is associated with increased sensitivity of platelet aggregation to adenosine diphosphate. [(abstract)] Arterioscler Thromb Vasc Biol. 29:e122.
41. Kumar B, Dreja K, Shah SS, Cheong A, Xu SZ, Sukumar P, Naylor J, Forte A, Cipollaro M, McHugh D, Kingston PA, Heagerty AM, Munsch CM, Bergdahl A, Hultgardh-Nilsson A, Gomez MF, Porter KE, Hellstrand P, Beech DJ. 2006. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res 98:557-563.
42. Langohr IM, HogenEsch H, Stevenson GW, Sturek M. 2008. Vascular-associated lymphoid tissue in swine (Sus scrofa). Comp Med 58:168-173.
43. Larsen MO, Juhl CB, Porksen N, Gotfredsen CF, Carr RD, Ribel U, Wilken M, Rolin B. 2005. β-Cell function and islet morphology in normal, obese, and obese β-cell mass-reduced Gottingen minipigs. Am J Physiol Endocrinol Metab 288:E412-E421.
44. Larsen MO, Rolin B. 2004. Use of the Gottingen minipig as a model of diabetes with special focus on type 1 diabetes research. ILAR J 45:303-313.
45. Larsen MO, Rolin B, Raun K, Bjerre Knudsen L, Gotfredsen CF, Bock T. 2007. Evaluation of β-cell mass and function in the Gottingen minipig. Diabetes Obes Metab 9 Suppl 2:170-179.
46. Larsen MO, Rolin B, Sturis J, Wilken M, Carr RD, Porksen N, Gotfredsen CF. 2006. Measurements of insulin responses as predictive markers of pancreatic β-cell mass in normal and β-cell-reduced lean and obese Gottingen minipigs in vivo. Am J Physiol Endocrinol Metab 290:E670-E677.
47. Larsen MO, Rolin B, Wilken M, Carr RD, Gotfredsen CF. 2003. Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic β-cell mass in vivo in the nicotinamide-streptozotocin Gottingen minipig, a model of moderate insulin deficiency and diabetes. Diabetes 52:118-123.
48. Larsen MO, Rolin B, Wilken M, Carr RD, Svendsen O. 2002. High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Gottingen minipig: results from a pilot study. Ann N Y Acad Sei 967:414-423.
49. Larsen MO, Wilken M, Gotfredsen CF, Carr RD, Svendsen O, Rolin B. 2002. Mild streptozotocin diabetes in the Göttingen minipig: a novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab 282:E1342-E1351.
50. Le TT, Langohr IM, Locker MJ, Sturek M, Cheng JX. 2007. Label-free molecular imaging of atherosclerotic lesions using multimodal nonlinear optical microscopy. J Biomed Opt 12:054007.
51. 2+ signaling, tyrosine phosphorylation, and coronary artery disease in diabetic dyslipidemic swine are prevented by atorvastatin. J Pharmacol Exp Ther 306:132-140.
52. Lee L, Alloosh M, Saxena R, Van Alstine W, Watkins BA, Klaunig JE, Sturek M, Chalasani N. 2009. Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Hepatology 50:56-67.
53. Levy J, Gavin JR, Sowers JR. 1994. Diabetes mellitus: A disease of abnormal cellular calcium metabolism? Am J Med 96:260-273.
54. Lloyd PG, Fang M, Brisbin IL Jr, Andersson L, Sturek M. 2006. AMP kinase gene mutation is consistent with a thrifty phenotype (metabolic syndrome) in a population of feral swine. FASEB J 20:A299.
55. Lloyd PG, Sheehy AF, Edwards JM, Mokelke EA, Sturek M. 2008. Leukemia inhibitory factor is upregulated in coronary arteries of Ossabaw miniature swine after stent placement. Coron Artery Dis 19:217-226.
56. Lovejoy JC, Windhauser MM, Rood JC, de la Bretonne JA. 1998. Effect of a controlled high-fat versus low-fat diet on insulin sensitivity and leptin levels in African-American and Caucasian women. Metabolism 47:1520-1524.
57. Lowe HC, Schwartz RS, Mac Neill BD, Jang IK, Hayase M, Rogers C, Oesterle SN. 2003. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv 60:515-523.
58. Maclean N, Ogilvie RF. 1955. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 4:367-376.
59. Martin RJ, Gobble JL, Hartsock TH, Graves HB, Ziegler JH. 1973. Characterization of an obese syndrome in the pig. Proc Soc Exp Biol Med 143:198-203.
60. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. 2001. A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170.
61. + current. Am J Physiol Heart Circ Physiol 288:H1233-H1241.
62. + channels in diabetic dyslipidemic pigs is prevented by exercise. J Appl Physiol 95:1179-1193.
63. Moreno PR, Fallon JT, Murcia AM, Leon MN, Simosa H, Fuster V, Palacios IF. 1999. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients. J Am Coll Cardiol 34:1045-1049.
64. Morgan KP, Kapur A, Beatt KJ. 2004. Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart 90:732-738.
65. Natali A, Vichi S, Landi P, Seven S, L'Abbate A, Ferrannini E. 2000. Coronary atherosclerosis in type II diabetes: angiographic findings and clinical outcome. Diabetologia 43:632-641.
66. Neeb ZP, Edwards JM, Bratz IN, Alloosh M, Schultz C, Thompson K, Cunha T, and Sturek M. 2008. Occlusive, diffuse coronary artery disease in Ossabaw miniature swine with metabolic syndrome. FASEB J 22:1152.10.
67. Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE. 2008. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 52:255-262.
68. Otis CR, Wamhoff BR, Sturek M. 2003. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine. Comp Med 53:53-64.
69. Owens GK, Kumar MS, Wamhoff BR. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767-801.
70. Panepinto LM, Phillips RW, Westmoreland NW, Cleek JL. 1982. Influence of genetics and diet on the development of diabetes in Yucatan miniature swine. J Nutr 112:2307-2313.
71. Peterson RG. 2001. The Zucker diabetic fatty (ZDF) rat, p 109-128. In: Sima AAF, Shafrir E, editors. Animal models of diabetes: a primer. Amsterdam (Netherlands): Harwood Academic Publishers.
72. Phillips RW, Panepinto LM, Spangler R, Westmoreland N. 1982. Yucatan miniature swine as a model for the study of human diabetes mellitus. Diabetes 31:30-36.
73. Phillips RW, Westmoreland N, Panepinto L, Case GL. 1982. Dietary effects on metabolism of Yucatan miniature swine selected for low and high glucose utilization. J Nutr 112:104-111.
74. Piatti P, Di Mario C, Monti LD, Fragasso G, Sgura F, Caumo A, Setola E, Lucotti P, Galluccio E, Ronchi C, Origgi A, Zavaroni I, Margonato A, Colombo A. 2003. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 108:2074-2081.
75. Pons D, Monraats PS, Zwinderman AH, de Maat MPM, Doevendans PAFM, de Winter RJ, Tio RA, Waltenberger J, Jukema JW. 2009. Metabolic background determines the importance of NOS3 polymorphisms in restenosis after percutaneous coronary intervention: a study in patients with and without the metabolic syndrome. Dis Markers 26:75-83.
76. Rana JS, Monraats PS, Zwinderman AH, de Maat MPM, Kastelein JJP, Doevendans PAF, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW. 2005. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention. Diabetes Care 28:873-877.
77. Rector RS, Thomas TR, Liu Y, Henderson KK, Holiman DA, Sun GY, Sturek M. 2004. Effect of exercise on postprandial lipemia following a higher calorie meal in Yucatan miniature swine. Metabolism 53:1021-1026.
78. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. 2002. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436-472. (Pubitemid 34174577)
79. Schwartz RS, Edelman ER. 2002. Drug-eluting stents in preclinical studies. Recommended evaluation from a consensus group. Circulation 106:1867-1873.
80. Sheehy A, Mokelke EA, Lloyd PG, Sturek J, Sturek M. 2006. Reduced expression of leukemia inhibitory factor correlates with coronary atherosclerosis in the metabolic syndrome. FASEB J 20:A698.
81. 2+ release from coronary smooth muscle sarcoplasmic reticulum. Am J Physiol 259:H643-H647.
82. Stehno-Bittel L, Laughlin MH, Sturek M. 1991. Exercise training depletes sarcoplasmic reticulum calcium in coronary smooth muscle. J Appl Physiol 71:1764-1773.
83. Sturek M, Alloosh M, Wenzel J, Byrd JP, Edwards JM, Lloyd PG, Tune JD, March KL, Miller MA, Mokelke EA, Brisbin IL Jr. 2007. Ossabaw Island miniature swine: cardiometabolic syndrome assessment, p 397-402. In: Swindle MM, editor. Swine in the laboratory: surgery, anesthesia, imaging, and experimental techniques. Boca Raton (FL): CRC Press.
84. Takagi T, Yoshida K, Akasaka T, Kaji S, Kawamoto T, Honda Y, Yamamuro A, Hozumi T, Morioka S. 2000. Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study. J Am Coll Cardiol 36:731-738.
85. Tommasino A, Burzotta F, Trani C, Giammarinaro M, Schiavoni G. 2008. Impact of metabolic syndrome on angiographic and clinical outcome after stenting. Am J Cardiol 101:1679.
86. Touchard AG, Schwartz RS. 2006. Preclinical restenosis models: challenges and successes. Toxicol Pathol 34:11-18.
87. Turk JR, Carroll JA, Laughlin MH, Thomas TR, Casati J, Bowles DK, Sturek M. 2003. C-reactive protein correlates with macrophage accumulation in coronary arteries of hypercholesterolemic pigs. J Appl Physiol 95:1301-1304.
88. Wallace TM, Levy JC, Matthews DR. 2004. Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495.
89. 2+ signaling. Am J Physiol Heart Circ Physiol 283:H2397-H2410.
90. 2+ channels modulate expression of smooth muscle differentiation marker genes via a Rho kinase-myocardin-SRF-dependent mechanism. Circ Res 95:406-414.
91. 2+ signaling associated with diabetic dyslipidemia. J Vasc Res 39:208-220.
92. Wang HW, Langohr IM, Sturek M, Cheng JX. 2009. Imaging and quantitative analysis of atherosclerotic lesions by CARS-based multimodal nonlinear optical microscopy. Arterioscler Thromb Vasc Biol 29:1342-1348.
93. 2+ precipitation procedure for quantitation of HDL cholesterol. Clin Chem 28:1379-1388.
94. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. 2005. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112:3066-3072.
95. Witczak CA, Mokelke EA, Boullion RD, Wenzel J, Keisler DH, Sturek M. 2005. Noninvasive measures of body fat percentage in male Yucatan swine. Comp Med 55:445-451.
96. Witczak CA, Sturek M. 2004. Exercise prevents diabetes-induced impairment in superficial buffer barrier in porcine coronary smooth muscle. J Appl Physiol 96:1069-1079.
97. 2+ influx. Med Sci Sports Exerc 37:1119-1125.
98. 2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic Yucatan swine. J Appl Physiol 101:752-762.